Senior Product Manager, Lyra Health
Bend Platform
$128-176k
+ Equity in the company through discretionary restricted stock units
1-2 days a week in office (Burlingame, CA)
Mental health employee benefits
Open for applications
Mental health employee benefits
1001+ employees
Open for applications
$128-176k
+ Equity in the company through discretionary restricted stock units
1-2 days a week in office (Burlingame, CA)
1001+ employees
Company mission
To transform access to life-changing mental health care.
Jump to section
Company mission
To transform access to life-changing mental health care.
40% employee growth in 12 months
Our take
In the US, millions of people suffer from mental illness each year. This is not only a detriment to individuals, but to businesses as well - with research suggesting that depression and anxiety disorders lead to $1 trillion in lost productivity worldwide each year.
Lyra Health is out to tackle these issues head-on, by delivering mental health care for employees. The company offers video counselling sessions and one-to-one messaging to help users with a variety of conditions including anxiety, depression and substance use disorder.
The company is a key player in the sector alongside peers like Calm, Genoa and Talkspace. Impressively, it boasts a 90% satisfaction rate across its more than 2 million members, demonstrating the impact its products can have.
In 2025, Lyra Health launched a ‘clinical-grade’ chatbot to its offering. This has been met with mixed feelings due to evidence that AI can act unpredictably in response to mental health concerns. It will take time to see whether this feature will enhance or diminish the user experience.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Monthly tech stipend
- Full access to Lyra’s mental health services for employees and their eligible dependents—at no charge
- 401k and equity options
- Medical, dental, and vision benefits, and free monthly membership to One Medical
- Four weeks of vacation and paid holidays
Funding (last 2 of 8 rounds)
Jan 2022
$35m
SERIES F
May 2021
$200m
SERIES F
Total funding: $690.1m
This company has top investors
Leadership
David Ebersman
(Co-Founder & Board Chair)Former CEO of the company. Was an Equity Research Analyst at Oppenheimer & Co. Also served as the CFO at Facebook, and worked at Genentech for 15 years, leaving as Chief Financial Officer & Executive VP.
Jennifer Schulz
(CEO)Former CEO of Experian North America, Head of Global Online and Digital Products at Visa, and CEO at Verifi.
Jobs (9)
Software Engineering
Data
People, HR, Recruitment
Finance, Legal & Compliance
Sales & Account Management